Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus.

Source:http://linkedlifedata.com/resource/pubmed/id/17191072

Download in:

View as

General Info

PMID
17191072